University of California, San Francisco

Cancer drugs: better, cheaper

Cancer drug development is known to be too slow, costly and fraught with failure. Now the U.S. Food and Drug Administration is issuing recommendations for breast cancer trials that would substantially accelerate patient access ...

Jun 04, 2012
popularity not rated yet | comments 0

For advanced prostate cancer, new drug slows disease

A new medication proved effective in slowing the spread of metastatic prostate cancer, while helping to maintain the quality of life, in patients with advanced disease. The phase 3 study was unblinded midway, allowing patients ...

Jun 02, 2012
popularity not rated yet | comments 0 | with audio podcast